[1] |
SINGER M, DEUTSCHMAN C S, SEYMOUR C W,et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3)[J]. JAMA, 2016, 315(8):801-810. DOI: 10.1001/jama.2016.0287.
|
[2] |
HUANG M, CAI S L, SU J Q. The pathogenesis of sepsis and potential therapeutic targets[J]. Int J Mol Sci, 2019, 20(21):5376. DOI: 10.3390/ijms20215376.
|
[3] |
ACKERMAN M H, AHRENS T, KELLY J,et al. Sepsis[J]. Crit Care Nurs Clin N Am, 2021, 33(4):407-418. DOI: 10.1016/j.cnc.2021.08.003.
|
[4] |
|
[5] |
ROHSISWATMO R, AZHARRY M, SARI T T,et al. TLR2 and TLR4 expressions in late-onset neonatal sepsis:is it a potential novel biomarker?[J]. J Neonatal Perinatal Med, 2021, 14(3):361-367. DOI: 10.3233/NPM-200411.
|
[6] |
XU X E, LIU L, WANG Y C,et al. Caspase-1 inhibitor exerts brain-protective effects against sepsis-associated encephalopathy and cognitive impairments in a mouse model of Sepsis[J]. Brain Behav Immun, 2019, 80:859-870. DOI: 10.1016/j.bbi.2019.05.038.
|
[7] |
STAN R C, SORIANO F G, DE CAMARGO M M. A mathematical model relates intracellular TLR4 oscillations to sepsis progression[J]. BMC Res Notes, 2018, 11(1):462. DOI: 10.1186/s13104-018-3561-9.
|
[8] |
KALIS C, KANZLER B, LEMBO A,et al. Toll-like receptor 4 expression levels determine the degree of LPS-susceptibility in mice[J]. Eur J Immunol, 2003, 33(3):798-805. DOI: 10.1002/eji.200323431.
|
[9] |
LIU Y, WANG R Z, CHENG J,et al. Ratio of serum procalcitonin to monocytic HLA-DR as a reliable parameter in prognosis prediction of sepsis[J]. Clin Chim Acta, 2021, 519:94-100. DOI: 10.1016/j.cca.2021.04.011.
|
[10] |
TAN J L, LI N, GONG Y L,et al. Procalcitonin kinetics early after severe burn injury and its value in diagnosis of sepsis[J]. Burns, 2021, 47(8):1802-1809. DOI: 10.1016/j.burns.2021.02.024.
|
[11] |
LI S H, RONG H M, GUO Q L,et al. Serum procalcitonin levels distinguish Gram-negative bacterial sepsis from Gram-positive bacterial and fungal Sepsis[J]. J Res Med Sci, 2016, 21:39. DOI: 10.4103/1735-1995.183996.
|
[12] |
COHEN J, VINCENT J L, ADHIKARI N K,et al. Sepsis:a roadmap for future research[J]. Lancet Infect Dis, 2015, 15(5):581-614. DOI: 10.1016/S1473-3099(15)70112-X.
|
[13] |
HORNIK C P, BENJAMIN D K, BECKER K C,et al. Use of the complete blood cell count in late-onset neonatal sepsis[J]. Pediatr Infect Dis J, 2012, 31(8):803-807. DOI: 10.1097/INF.0b013e31825691e4.
|
[14] |
VAN DER POLL T, SHANKAR-HARI M, WIERSINGA W J. The immunology of sepsis[J]. Immunity, 2021, 54(11):2450-2464. DOI: 10.1016/j.immuni.2021.10.012.
|
[15] |
KOBASHI H, TOSHIMORI J, YAMAMOTO K. Sepsis-associated liver injury:incidence,classification and the clinical significance[J]. Hepatol Res, 2013, 43(3):255-266. DOI: 10.1111/j.1872-034X.2012.01069.x.
|
[16] |
MUADY G F, BITTERMAN H, LAOR A,et al. Hemoglobin levels and blood transfusion in patients with sepsis in Internal Medicine Departments[J]. BMC Infect Dis, 2016, 16(1):569. DOI: 10.1186/s12879-016-1882-7.
|
[17] |
|
[18] |
INANDIKLIOGLU N, DOGANYIGIT Z, OKAN A,et al. Nephroprotective effect of apilarnil in lipopolysaccharide-induced Sepsis through TLR4/NF-κB signaling pathway[J]. Life Sci, 2021, 284:119875. DOI: 10.1016/j.lfs.2021.119875.
|
[19] |
CIESIELSKA A, MATYJEK M, KWIATKOWSKA K. TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling[J]. Cell Mol Life Sci, 2021, 78(4):1233-1261. DOI: 10.1007/s00018-020-03656-y.
|
[20] |
KUZMICH N N, SIVAK K V, CHUBAREV V N,et al. TLR4 signaling pathway modulators as potential therapeutics in inflammation and sepsis[J]. Vaccines(Basel), 2017, 5(4):E34. DOI: 10.3390/vaccines5040034.
|
[21] |
KUMAR V. Toll-like receptors in Sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets[J]. Int Immunopharmacol, 2020, 89(Pt B):107087. DOI: 10.1016/j.intimp.2020.107087.
|
[22] |
BOLANAKI M, MÖCKEL M, WINNING J,et al. Diagnostic performance of procalcitonin for the early identification of sepsis in patients with elevated qSOFA score at emergency admission[J]. J Clin Med, 2021, 10(17):3869. DOI: 10.3390/jcm10173869.
|
[23] |
THOMAS-RÜDDEL D O, GROUP F T M S, POIDINGER B,et al. Influence of pathogen and focus of infection on procalcitonin values in sepsis patients with bacteremia or candidemia[J]. Crit Care, 2018, 22:128. DOI: 10.1186/s13054-018-2050-9.
|
[24] |
|